Skip to content

    ABBOTT LABORATORIES

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $10.38B
    $10.63B
    $10.97B
    $10.36B
    $11.14B
    +7.4%
    $11.37B
    +6.9%
    $11.46B
    +4.4%
    $11.16B
    +7.8%
    Strengthening
    Operating Profit
    $1.67B
    $1.86B
    $1.91B
    $1.69B
    $2.05B
    +22.9%
    $2.06B
    +10.7%
    $2.25B
    +17.8%
    $1.34B
    -20.6%
    Stable
    Net Profit
    $1.30B
    $1.65B
    $9.23B
    $1.32B
    $1.78B
    +36.6%
    $1.64B
    -0.1%
    $1.78B
    -80.8%
    $1.08B
    -18.7%
    Weakening
    EPS
    $0.74
    $0.94
    $0.76
    $1.02
    +37.8%
    $0.94
    +0.0%
    $0.62
    -18.4%
    Weakening
    Other Income
    Interest
    $140.00M
    $142.00M
    $136.00M
    $131.00M
    $121.00M
    -13.6%
    $121.00M
    -14.8%
    $120.00M
    -11.8%
    $174.00M
    +32.8%
    Stable
    Depreciation
    Profit before Tax
    $1.61B
    $1.94B
    $2.03B
    $1.78B
    $2.15B
    +33.8%
    $2.18B
    +12.4%
    $2.36B
    +16.2%
    $1.45B
    -18.5%
    Strengthening
    MarginsOPM
    16.1%
    17.5%
    17.4%
    16.3%
    18.4%
    +14.6%
    18.1%
    +3.5%
    19.6%
    +12.8%
    12.1%
    -26.3%
    Weakening
    Tax
    19.0%
    15.2%
    -354.6%
    25.5%
    17.3%
    -9.1%
    24.6%
    +62.3%
    24.7%
    25.7%
    +0.7%
    Strengthening
    ReturnsROIC
    1.7%
    2.2%
    12.3%
    1.8%
    2.4%
    +36.6%
    2.2%
    -0.1%
    2.4%
    -80.8%
    1.4%
    -18.7%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$3.84B$3.86B$6.84B$9.80B$9.88B$6.90B$7.62B$8.52B$6.80B
    Short-Term Investments
    Total Current Assets$14.63B$15.67B$20.44B$24.24B$25.22B$22.67B$23.66B$26.00B$25.51B
    Net PP&E$7.56B$8.97B$10.13B$10.11B$10.28B$11.28B$11.73B$12.94B$12.38B
    Goodwill$23.25B$23.20B$23.74B$23.23B$22.80B$23.68B$23.11B$24.04B$35.22B
    Intangibles$18.94B$17.02B$14.78B$12.74B$10.45B$8.81B$6.65B$5.53B$17.88B
    Total Assets$67.17B$67.89B$72.55B$75.20B$74.44B$73.21B$81.41B$86.71B$110.43B
    LiabilitiesTotal Current Liabilities$9.01B$10.86B$11.91B$13.11B$15.49B$13.84B$14.16B$16.50B$18.38B
    Short-Term Debt$7.00M$1.28B$7.00M$754.00M$2.25B$1.08B$1.50B$3.03B$4.41B
    Long-Term Debt$19.36B$16.66B$18.53B$17.30B$14.52B$13.60B$12.63B$9.90B$29.64B
    Long-Term Leases$755.00M$902.00M$956.00M$943.00M$949.00M$896.00M$931.00M
    Total Liabilities$36.45B$36.59B$39.55B$39.17B$37.53B$34.39B$33.51B$33.94B$57.73B
    EquityCommon Stock & APIC$23.51B$23.85B$24.14B$24.47B$24.71B$24.87B$25.15B$25.53B$25.35B
    Retained Earnings$24.56B$25.85B$27.63B$31.53B$35.26B$37.55B$47.26B$49.78B$49.96B
    Total Equity$30.52B$31.09B$32.78B$35.80B$36.69B$38.60B$47.66B$52.13B$52.06B
    HighlightsNet Cash / (Debt)-$15.52B-$14.08B-$11.70B-$8.25B-$6.89B-$7.78B-$6.51B-$4.41B-$27.24B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$6.30B$6.14B$7.90B$10.53B$9.58B$7.26B$8.56B$9.57B$9.46B
    Cash from Investing-$1.36B-$1.81B-$2.21B-$2.01B-$1.74B-$3.13B-$2.34B-$2.42B-$22.28B
    Cash from Financing-$10.39B-$4.29B-$2.78B-$5.49B-$7.64B-$7.09B-$5.40B-$6.31B$13.06B
    SummaryCapital Expenditure-$1.39B-$1.64B-$2.18B-$1.89B-$1.78B-$2.20B-$2.21B-$2.17B-$2.09B
    Free Cash Flow$4.91B$4.50B$5.72B$8.65B$7.80B$5.06B$6.35B$7.39B$7.38B
    FCF Margin16.0%14.1%16.5%20.1%17.9%12.6%15.1%16.7%16.3%